172 related articles for article (PubMed ID: 9509302)
1. Glycopathological study of eyelid tumors and pseudotumors.
Uehara F; Yonezawa S; Sato E; Ohba N
Jpn J Ophthalmol; 1997; 41(6):362-9. PubMed ID: 9509302
[TBL] [Abstract][Full Text] [Related]
2. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
3. Eyelid tumors: clinical data from an eye center in Ankara, Turkey.
Gundogan FC; Yolcu U; Tas A; Sahin OF; Uzun S; Cermik H; Ozaydin S; Ilhan A; Altun S; Ozturk M; Sahin F; Erdem U
Asian Pac J Cancer Prev; 2015; 16(10):4265-9. PubMed ID: 26028084
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature.
Deprez M; Uffer S
Am J Dermatopathol; 2009 May; 31(3):256-62. PubMed ID: 19384066
[TBL] [Abstract][Full Text] [Related]
6. MUC1 and sialoglycan expression associated with cytotoxic T lymphocyte infiltration in eyelid malignant tumors.
Uehara F; Ohba N
Jpn J Ophthalmol; 2002; 46(3):237-43. PubMed ID: 12063031
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
Sinard JH
Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
[TBL] [Abstract][Full Text] [Related]
10. Malignant tumor of the eyelid--clinical survey during 22-year period.
Abe M; Ohnishi Y; Hara Y; Shinoda Y; Jingu K
Jpn J Ophthalmol; 1983; 27(1):175-84. PubMed ID: 6855011
[TBL] [Abstract][Full Text] [Related]
11. Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
Yunoki T; Tabuchi Y; Hayashi A
Anticancer Res; 2017 Apr; 37(4):1931-1934. PubMed ID: 28373462
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
13. Basal cell, squamous cell, and sebaceous gland carcinomas of the periorbital region.
Lober CW; Fenske NA
J Am Acad Dermatol; 1991 Oct; 25(4):685-90. PubMed ID: 1791226
[TBL] [Abstract][Full Text] [Related]
14. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and behavior of eyelid carcinoma (basal cell, squamous cell sebaceous gland, and malignant melanoma).
Loeffler M; Hornblass A
Ophthalmic Surg; 1990 Jul; 21(7):513-8. PubMed ID: 2204856
[TBL] [Abstract][Full Text] [Related]
16. Eyelid tumors in Siriraj Hospital from 2000-2004.
Pornpanich K; Chindasub P
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S11-4. PubMed ID: 16681045
[TBL] [Abstract][Full Text] [Related]
17. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
18. Patterns of lymphatic spread and the management of eyelid carcinomas.
Hashimoto K; Yasumatsu R; Toh S; Shiratsuchi H; Yoshida T; Nishiyama K; Yoshikawa H; Nakashima T; Nakagawa T
Auris Nasus Larynx; 2016 Dec; 43(6):666-71. PubMed ID: 26965587
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.
Chao AN; Shields CL; Krema H; Shields JA
Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
